Piper Sandler Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $76

Futu NewsJan 14 20:31 · Ratings

Piper Sandler Remains a Buy on Biohaven Ltd. (BHVN)

TipRanksJan 14 19:58 · Ratings

What's Going On With Merus Stock Monday?

BenzingaJan 14 05:17

Merus Shares Are Trading Lower. The Company Announced a Research Collaboration and License Agreement With Biohaven to Co-develop Three Novel Bispecific Antibody Drug Conjugates.

BenzingaJan 14 01:52

Biohaven Showcases TRAP Degraders at J.P. Morgan Conference

TipRanksJan 14 00:48

Merus, Biohaven Partner to Develop Bispecific Therapies for Cancers

MT NewswiresJan 13 17:49